npj Precision Oncology is a new open-access journal committed to publishing cutting edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine.
Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapiesdoi:10.3390/onco3030010STEM cell transplantationESOPHAGEAL cancerDRUG therapyVASCULAR endothelial growth factor receptorsTREATMENT effectiveness...
IMPACT2, TAPUR, NCI-MATCH, DART [for rare cancers]) or for prostate cancer (STAMPEDE). The efficacy of the precision medicine approach was first demonstrated in IMPACT1. That trial deployed tumor molecular profiling to match patients
Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total...
et al. Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses. Clin. Cancer Res. 20, 4827–4836 (2014). Article CAS PubMed PubMed Central Google Scholar Schwaederle, M. et al. Impact of precision medicine in diverse...
Artificial intelligence has made significant contributions to oncology through the availability of high-dimensional datasets and advances in computing and deep learning. Cancer precision medicine aims to optimize therapeutic outcomes and reduce side effe
Platform trials have resulted in the treatment of patients with cancer with genomically matched or immune-targeted agents across tumor types (IMPACT1, IMPACT2, TAPUR, NCI-MATCH, DART [for rare cancers]) or for prostate cancer (STAMPEDE). The efficacy of the precision medicine approach was first...
Genome Medicine is pleased to present a special issue on Precision Cancer Medicine. It explores how genomics is providing a detailed understanding of cancer and how next generation sequencing can aid diagnosis and guide the development of targeted therapies. This collection of articles has not been ...
Liver cancer is one of the most common malignancies with the sixth highest incidence rate and the second highest mortality among the death spectrum of cancers worldwide. Most often, liver cancer patients are usually in their advanced stages that have los
Cancer incidence is rising in Italy, making it harder for researchers to search for innovative and comprehensive treatment strategies. The advancement of p